英文名稱 | Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody) |
---|---|
中文名稱 | 盧利珠單抗 |
CAS號(hào) | 220651-94-5 |
儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥3200.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥15800.00 | 登錄后可見(jiàn) | |
10 mg | 3-5days | ¥28600.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥128000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥236000.00 | 登錄后可見(jiàn) |
英文名稱 | Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody) |
---|---|
中文名稱 | 盧利珠單抗 |
CAS號(hào) | 220651-94-5 |
儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
Ruplizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized monoclonal antibody targeting CD40L(TNF Receptor). It has the potential for systemic lupus erythematosus disease research. MW :145.68 KD.